New UK facility

RNS Number : 8441Y

Advanced Medical Solutions Grp PLC

11 July 2008

 



For immediate release

11 July 2008

RNS REACH

Advanced Medical Solutions Group plc 

('AMS' or 'the Company')

Secures site for major new facility in North West

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, today announces that it has agreed a pre-let for the lease of a 138,500 sq ft bespoke building on the Premier Park industrial complex in Winsford, Cheshire, for development into a new facility comprising offices, R&D laboratories, manufacturing and warehousing. AMS' decision to rationalise its  operations in the North West was initially announced in the 2007 Annual Report and Accounts.

Patrick Properties, a North West property investment and development company, will start work on the new building in the next few weeks with hand over to AMS expected in early 2009 for fitting out.

AMS currently has two operations on the Winsford Industrial Estate, employing 150 people who will transfer to the new facility during 2009 and 2010. The new facility has been sized to accommodate AMS' existing operations and allows for future expansion. A 15 year lease, with an option to extend, has been agreed for the new building.  

The project, which is a major commitment to R&D and manufacturing in the UK has been supported by the North West Development Agency (NWDA).

The NWDA has identified the biomedical sector as strategically important to the growth of the economy in the North West. The region is home to one of the top three biomedical and healthcare clusters in the UK. NWDA, which engages actively with leading companies in the region to help identify and support major opportunities for growth in strategic sectors, has identified Advanced Medical Solutions as an innovative healthcare company that is growing strongly in the heart of Cheshire.  After sharing and understanding the Company's vision and plans, NWDA has made an offer of £275,000 to support this major investment under the Selective Finance for Investment in England Scheme.

Commenting on this announcement, Dr. Don Evans, Chief Executive of AMS, stated:

'I am delighted that we have managed to secure a prime site for this new facility in the local area thus retaining key staff and skills and mitigating the disruption risks associated with a major project of this kind.  This is a key investment for AMS, which will  allow us to consolidate our existing operations in a state of the art facility, support our growth plans and further strengthen our position as a leading technology driven, medical device company.'

For further information, please contact:

Advanced Medical Solutions Group plc
Don Evans, Chief Executive Officer Mary Tavener, Finance Director www.admedsol.com	Tel: [phone]
Buchanan Communications	Tel: [phone]
Mark Court, Mary-Jane Johnson, Stasa Filiplic
Landsbanki Securities (UK) Ltd Shaun Dobson, Claes Spang	Tel: [phone]

Notes to Editors:

Advanced Medical Solutions is a leading company in the development, manufacture and sale of products into the $15 billion global woundcare market.

Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative products for advanced woundcare and wound closure.

In-house natural and synthetic polymer technology is used to provide advanced wound dressings based on the moist healing principle. AMS' resources ensure a unique position as a vertically integrated 'one stop shop' to provide all categories of moist wound healing products. The Company has the capability to move a product from design and development through to production and delivery ready for distribution into customer markets.

AMS' technology in cyanoacrylate based tissue adhesives is used either for the closure of small cuts and trauma wounds through to large surgical incisions, or for protecting or sealing skin to prevent breakdown or infection. 

AMS' products currently serve the majority of the key global markets sold either direct or through strategic partners or distributors.

 

END

 

 

NRAQBLFFVDBZBBB